Did you  miss the PACE 2013 Snapshot session held in Amsterdam? View the 3 minute webcasts with faculty members for a short overview 

Webcast • Snapshot 2013

Options left for HDL therapies

Snapshot 2013 Prof. Bryan Brewer (Washington DC, USA) discusses the options left for HDL therapies to reduce the residual risk in statin therapy. What are the HDL therapies in active investigation?

Webcast • Snapshot 2013

Inflammation: targets for intervention

Snapshot 2013 Prof. Ulf Landmesser (University Hospital Zurich, CH) provides an overview of the targets for intervention in the inflammatory process in cardiovascular disease.

Webcast • Snapshot 2013

HoFH: Prevalence and new treatments

Dr. Kees Hovingh, Amsterdam, reviews recent data on the prevalence, phenotype and novel treatment options for patients with Homozygous Familial Hypercholesterolaemia

Webcast • Snapshot 2013

Targeting fasting and post-prandial triglycerides

Dr. Joanne Donovan, describes a potential novel approach to target fasting and post-prandial triglycerides with an oral agent that targets intestinal and liver PCSK9

Webcast • Amsterdam, August 31, 2013

Therapy resistant hypertension: novel pharmacotherapy or renal denervation?

Prof. Luis Ruilope about current options to manage therapy resistant hypertension.

Webcast • Amsterdam, August 31, 2013

Therapeutic innovations for severe hypertriglyceridemia

Prof. Daniel Gaudet reviews the effects of a new antisense-based therapy on the potential treatment of severe hypertriglyceridemia.

Webcast • Amsterdam, August 31, 2013

PCSK9 & LDL- The best story of translational medicine?

Dr Evan Stein with a short overview of current status of development of PCSK9 inhibitors